Gregory Makris: Factor XI Makes the Leap from OCEANIC Stroke to the ESO 2025 Update
Gregory Makris, Senior Director in Global Medical Affairs, Cardiovascular and Thrombosis at Bayer, shared on LinkedIn:
”Stroke medicine is evolving rapidly, with emerging evidence continuously informing clinical practice!
A few days after the release of the OCEANIC Stroke trial, it is great to see Factor XI making it to the European Stroke Organisation annual stroke evidence update for 2025!
There is no time to lose when it comes to preventing secondary strokes!”
Title: ESO annual stroke evidence update 2025
Authors: Diana Aguiar de Sousa, Aristeidis H Katsanos, Linxin Li, Nicolas Martinez-Majander, John McCabe, Lina Palaiodimou, Anna Ramos Pachon, Michele Romoli, Peter D Schellinger, Annaelle Zietz, Sven Poli, Melinda Roaldsen, Ashkan Shoamanesh, Marek Sýkora, Georgios Tsivgoulis
Read the Full Article on European Stroke Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia
-
Aug 23, 2026, 16:03Balaji Balagani: Major Causes of Sudden Cardiac Death in Children
-
Aug 23, 2026, 16:02Bartosz Hudzik: What’s Hot at ESC Congress 2026